Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone and Bevacizumab for Retinal Vein Occlusion
NCT00805064Phase 3Completed
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- Jan 2006
- Primary completion
- Dec 2007
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
01
Overview
A Phase 3 trial of triamcinolone, bevacizumab in retinal vein occlusion (RVO), sponsored by Universitätsklinikum Frankfurt. Started Jan 2006; status: completed.
02
Drugs
triamcinolonebevacizumab
03
Conditions
retinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT00805064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805064.